Movicol Chocolate Sachet

Macrogol 3350, the active ingredient in Movicol Chocolate Sachet, is an osmotic laxative presented as a powder for oral solution (sachet) for oral use. It is employed to relieve constipation, treat faecal impaction, and prepare the bowel for diagnostic procedures.

GNH USA supplies Movicol Chocolate Sachet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics across multiple markets, and the company adheres to stringent manufacturing standards and provides comprehensive support for product registration and distribution.

Movicol Chocolate Sachet, an osmotic laxative, is indicated for conditions affecting bowel function.

- Constipation: softens stool and facilitates regular bowel movements in patients with chronic or acute constipation, reducing straining and discomfort. - Faecal impaction: helps to break down hardened stool masses, enabling safe evacuation and relieving obstruction symptoms in individuals with impacted feces. - Bowel preparation for diagnostic procedures: clears the intestinal tract to improve visibility during colonoscopy, sigmoidoscopy, or radiographic examinations, ensuring accurate diagnostic outcomes.

Movicol Chocolate Sachet may cause a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Diarrhoea - Abdominal pain - Headache

Serious or Rare Side Effects: - Severe dehydration - Electrolyte imbalance (e.g., hyponatraemia, hypokalaemia) - Allergic reactions such as rash, angioedema, or anaphylaxis - Intestinal obstruction in patients with pre‑existing bowel disorders

Before prescribing Movicol Chocolate Sachet, healthcare professionals should consider several precautionary measures to ensure safe use.

- Assess renal function: evaluate kidney performance, as impaired clearance may affect fluid balance. - Monitor electrolytes: check serum sodium, potassium, and chloride levels during treatment. - Use with caution in dehydration: patients should be re‑hydrated before initiating therapy. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Caution in bowel obstruction: contraindicated in complete mechanical obstruction without medical supervision. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Macrogol 3350 can interact with other medicines, influencing their absorption or electrolyte status.

Major Interactions (Avoid): - Other osmotic laxatives (e.g., lactulose, sorbitol): combined use may cause excessive fluid loss and electrolyte disturbances. - High‑dose mineral supplements (e.g., potassium, magnesium): additive effects on electrolyte balance can be hazardous.

Moderate Interactions (Monitor Closely): - Oral antibiotics: accelerated gastrointestinal transit may reduce antibiotic absorption and efficacy. - Antidiabetic agents: altered carbohydrate absorption could affect glucose control. - Thyroid hormone preparations: increased bowel motility may diminish hormone absorption.